Nothing Special   »   [go: up one dir, main page]

ATE302947T1 - Verfahren zum nachweis eines lipoprotein- akutphaseprotein-komplexes - Google Patents

Verfahren zum nachweis eines lipoprotein- akutphaseprotein-komplexes

Info

Publication number
ATE302947T1
ATE302947T1 AT01944378T AT01944378T ATE302947T1 AT E302947 T1 ATE302947 T1 AT E302947T1 AT 01944378 T AT01944378 T AT 01944378T AT 01944378 T AT01944378 T AT 01944378T AT E302947 T1 ATE302947 T1 AT E302947T1
Authority
AT
Austria
Prior art keywords
patient
complex
acute phase
phase protein
lipoprotein
Prior art date
Application number
AT01944378T
Other languages
English (en)
Inventor
Timothy J Fischer
Colin Downey
Mike Nesheim
John A Samis
Liliana Tejidor
Cheng Hock Toh
John B Walker
Original Assignee
Bio Merieux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux Inc filed Critical Bio Merieux Inc
Application granted granted Critical
Publication of ATE302947T1 publication Critical patent/ATE302947T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/557—Immunoassay; Biospecific binding assay; Materials therefor using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT01944378T 2000-06-09 2001-06-08 Verfahren zum nachweis eines lipoprotein- akutphaseprotein-komplexes ATE302947T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59164200A 2000-06-09 2000-06-09
PCT/US2001/018611 WO2001096864A2 (en) 2000-06-09 2001-06-08 A method for detecting a lipoprotein-acute phase protein complex

Publications (1)

Publication Number Publication Date
ATE302947T1 true ATE302947T1 (de) 2005-09-15

Family

ID=26680497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01944378T ATE302947T1 (de) 2000-06-09 2001-06-08 Verfahren zum nachweis eines lipoprotein- akutphaseprotein-komplexes

Country Status (10)

Country Link
US (1) US20070155018A1 (de)
EP (1) EP1309857B1 (de)
JP (1) JP5051960B2 (de)
AT (1) ATE302947T1 (de)
AU (2) AU2001266795B2 (de)
BR (1) BR0111987A (de)
CA (1) CA2412317C (de)
DE (1) DE60112949T2 (de)
MX (1) MXPA02012176A (de)
WO (1) WO2001096864A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005519267A (ja) 2002-02-27 2005-06-30 バイオメリュー・インコーポレイテッド 止血機能不全、重症感染及び全身性炎症反応症候群を診断し、監視するための方法
EP1575978A4 (de) 2002-11-12 2006-04-19 Becton Dickinson Co Sepsis- oder sirs-diagnose mittels biomarkerprofilen
BR0316232A (pt) 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia, para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo
WO2006060386A1 (en) * 2004-12-01 2006-06-08 Biomerieux, Inc. Method for diagnosing critically ill patients
KR20080006617A (ko) 2005-04-15 2008-01-16 백톤 디킨슨 앤드 컴퍼니 패혈증의 진단
JP5125608B2 (ja) * 2008-02-28 2013-01-23 東ソー株式会社 イオン交換クロマトグラフィーによる血液中のＬｐ（ａ）の分離方法
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
GB201223079D0 (en) 2012-12-20 2013-02-06 Sepsis Ltd Point of care sepsis assay device and method
GB201301611D0 (en) 2013-01-30 2013-03-13 Shaw Andrew M Systems and methods for medical data processing and analysis
GB202004047D0 (en) 2020-03-20 2020-05-06 Ainger Phill Point of care sepsis assay device and method
CN113252852B (zh) * 2021-06-04 2021-10-22 金科环境股份有限公司 絮凝剂性能评价与检验设备及方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6429017B1 (en) * 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample

Also Published As

Publication number Publication date
US20070155018A1 (en) 2007-07-05
CA2412317A1 (en) 2001-12-20
DE60112949D1 (de) 2005-09-29
CA2412317C (en) 2016-03-22
JP5051960B2 (ja) 2012-10-17
BR0111987A (pt) 2003-10-28
DE60112949T2 (de) 2006-05-18
MXPA02012176A (es) 2004-08-19
WO2001096864A2 (en) 2001-12-20
AU2001266795B2 (en) 2006-07-13
WO2001096864A3 (en) 2003-02-06
JP2004503254A (ja) 2004-02-05
EP1309857A2 (de) 2003-05-14
EP1309857B1 (de) 2005-08-24
AU6679501A (en) 2001-12-24

Similar Documents

Publication Publication Date Title
ATE489633T1 (de) Verfahren zum frühzeitigen nachweis herzerkrankungen
DE50111644D1 (de) Verfahren und vorrichtung zum nachweisen von substanzen in körperflüssigkeiten mittels raman-spektroskopie
WO2004113912A8 (en) System and method for determining a temperature during analysis of biological fluid
ATE509275T1 (de) Schnelltest für glykiertes albumin
DE60128249D1 (de) Verfahren zur diagnose von immunologischer lebensmittelsensitivität
ATE497361T1 (de) Verfahren zum nachweis von mehreren analyten
DE59504495D1 (de) Verfahren und vorrichtung zur analyse von glucose in einer biologischen probe
DE602004030586D1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
DE69910003D1 (de) Überwachung physiologischer analyte
EA200600893A1 (ru) Определение гематокрита и концентрации аналита
ATE302947T1 (de) Verfahren zum nachweis eines lipoprotein- akutphaseprotein-komplexes
ATE316653T1 (de) Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe
US5197017A (en) Potentiophotometric fibrinogen determination
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
ATE403012T1 (de) Schnelle quantitative messung von löslichem fibrin in opaken körperflüssigkeiten
DE50104561D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
DE60025170D1 (de) Diagnostisches verfahren für asthma
Omote et al. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers
WO1996016588A3 (en) Method and apparatus for diagnosing capillary leak
ATE377191T1 (de) Verfahren zur analyse von stuhlproben für diagnostische zwecke
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
DE69929817D1 (de) Verfahren zur aktivitätsbestimmung einer substanz mittels eines funktionellen in vitro tests
NO20016080D0 (no) Analyse
ATE466285T1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties